Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6474066 | 1.00 | SLC29A1 (0.68) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL31307308 | 0.94 | SLC29A1 (0.71) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL31307319 | 0.93 | SLC29A1 (0.73) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL20419163 | 0.92 | SLC29A1 (0.72) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL5195359 | 0.92 | SLC29A1 (0.72) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL31307310 | 0.92 | SLC29A1 (0.67) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL24920112 | 0.90 | ADORA2A (0.67) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL30208521 | 0.90 | ADORA2A (0.67) | SLC29A1ADORA2AADORA2B | |
| SCHEMBL3997278 | 0.88 | CYP1A2 (0.64) | SLC29A1 | |
| SCHEMBL6536451 | 0.88 | CYP1A2 (0.64) | SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423252-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN FOREBRAIN NEURAL PROGENITOR CELLS AND FOR MATURATION THEREOF TO PARVALBUMIN+ INTERNEURONS | Trailhead Biosystems Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| CN-118591620-A | Methods and compositions for generating and maturing human forebrain neural progenitor cells into small albumin positive interneurons | 特雷尔赫德生物系统股份有限公司 | 2024-09-03 | — | — | CN | claimed |
| US-20230332103-A1 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | TRAILHEAD BIOSYSTEMS INC. | 2023-10-19 | — | — | US | claimed |
| WO-2023075913-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN FOREBRAIN NEURAL PROGENITOR CELLS AND FOR MATURATION THEREOF TO PARVALBUMIN+ INTERNEURONS | TRAILHEAD BIOSYSTEMS INC. (US) | 2023-05-04 | — | — | WO | claimed |
| EP-1583541-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | Neuronova AB (SE) | 2005-10-12 | — | — | EP | claimed |
| WO-2004045592-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | NEURONOVA AB (SE) | 2004-06-03 | — | — | WO | claimed |
| CN-120157727-A | Chemically modified adenine nucleoside triphosphate and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2025-06-17 | — | — | CN | disclosed |
| US-20240417726-A1 | miRNA REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-12-19 | — | — | US | disclosed |
| WO-2024250923-A1 | CHEMICALLY MODIFIED NUCLEOSIDE, CHEMICALLY MODIFIED NUCLEOSIDE TRIPHOSPHATE AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2024-12-12 | — | — | WO | disclosed |
| WO-2024182435-A1 | CONSTRUCTS FOR REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4423252-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN FOREBRAIN NEURAL PROGENITOR CELLS AND FOR MATURATION THEREOF TO PARVALBUMIN+ INTERNEURONS | Trailhead Biosystems Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118591620-A | Methods and compositions for generating and maturing human forebrain neural progenitor cells into small albumin positive interneurons | 特雷尔赫德生物系统股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20230332103-A1 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | TRAILHEAD BIOSYSTEMS INC. | 2023-10-19 | — | — | US | disclosed |
| WO-2023070130-A2 | MIRNA REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLS | THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-3638265-A1 | REPROGRAMMING FIBROBLASTS TO RETINAL CELLS | University of North Texas Health Science Center (US) | 2020-04-22 | — | — | EP | disclosed |
| WO-2018232258-A1 | REPROGRAMMING FIBROBLASTS TO RETINAL CELLS | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER (US) | 2018-12-20 | — | — | WO | disclosed |
| EP-1583541-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | Neuronova AB (SE) | 2005-10-12 | — | — | EP | disclosed |
| EP-1466004-A1 | PROCESS FOR THE SELECTIVE ENZYMATIC HYDROLYSIS OF NUCLEOSIDE POLYESTERS | Innovate Biotechnology S.R.L. (IT) | 2004-10-13 | — | — | EP | disclosed |
| WO-2004045592-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | NEURONOVA AB (SE) | 2004-06-03 | — | — | WO | disclosed |
| WO-2003057894-A1 | PROCESS FOR THE SELECTIVE ENZYMATIC HYDROLYSIS OF NUCLEOSIDE POLYESTERS | INNOVATE BIOTECHNOLOGY S.R.L. (IT) | 2003-07-17 | — | — | WO | disclosed |